| 1/22 | US=12 / Pelvis Pinho M. Marcadores tumorais em câncer colorretal. In: Rossi BM, Nakagawa WT, Ferreira FO, Aguiar Júnior S, Lopes A. Câncer de cólon, reto e ânus. São Paulo: Lemar, 2005. p. 87-104. MARCADORES TUMORAIS; ANTIGENO CARCINOEMBRIONICO; DIAGNOSTICO E RASTREAMENTO POPULACIONAL; AVALIACAO PROGNOSTICA PRE-OPERATORIA; ANTIGENO CARBOIDRATO 19-9; TIMIDILATO SINTETASE; ANALISE DO PERFIL GENOMICO TUMORAL; SURVIVINA; ANGIOGENESE; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; INDICADORES GENOMICOS RELACIONADOS AO POTENCIAL METASTATICO; DCC; OUTRAS MOLECULAS DE ADESAO E MEMBRANA; ANALISE DE GENES EM BLOCO; INSTABILIDADE DE MICROSSATELITES; MICROSSATELITES; DIAGNOSTICO DE INSTABILIDADE DE MICROSSATELITES; RELACAO ENTRE IMS E CANCER HEREDITARIO |
| 2/22 | US=22-A / Câncer Yao JC, Rindi G, Evans DB. Pancreatic endocrine tumors. In: DeVita Jr V, Lawrence TS, Rosenberg AS. DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 1702-21. EPIDEMIOLOGIA; CLASSIFICACAO DO TUMOR; HISTOPATOLOGIA; GENETICA MOLECULAR; IMUNOISTOQUIMICA MARCADOR MINIMO; TUMOR ENDOCRINO PANCREATICO; TUMORES FUNCIONAIS; INSULINOMA; TUMORES ENDOCRINOS FUNCIONAIS RAROS; EMERGENCIA TERPEUTICA; RADIOTERAPIA PEPETIDEO RECEPTORA; FATOR DE CRESCIMENTO ENDOTELIAL |
| 3/22 | US=3 / Gastro Khandekar JD, Khandekar M. Systemic therapy for gastric cancer. In: Gore RM. Gastric cancer. New York: Cambridge University Press, 2010. p. 98-119. (Contemporary issues in cancer imaging) ISBN 978-0-521-51383-8. CANCER GASTRICO; TERAPIA SISTEMICA; QUIMIOTERAPIA SISTEMICA; COMBINACAO QUIMIOTERAPICA; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; QUIMIOTERAPIA NEOADJUVANTE; IMUNOQUIMIOTERAPIA |
| 4/22 | US=6 / Ortopedia Podolanczuk A, Psaila B, Lyden D. Role of bone microenvironment/matastatic niche in cancer progression. In: Bronner F, Farac-Carson MC. Bone and cancer. New York: Springer-Verlag, 2009. p. 89-101. (Topics in bone biology) ISBN 978-1-84882-018-0. MICROAMBIENTE OSSEO; NICHO METASTATICO; CANCER; FATOR DE CRESCIMENTO DERIVADO DO TUMOR; CITOCINAS; QUIMIOCINAS; FATORES DE CRESCIMENTO ANGIOGENICO; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; MEDULA OSSEA; METASTASE; REGULACAO GENETICA |
| 5/22 | US=8 / Cab/Pescoço Lai SY, Grandis JR. Targeted therapeutic approaches to head and neck cancer. In: Snow JB Jr, Wackym PA. Ballenger's otorhinolaryngology head and neck surgery. 17ª ed. Lewiston: BC Decker, 2009. p. 1035-41. ISBN 1-55009-337-7. CANCER DE CABECA E PESCOCO; DIRECIONAMENTO MOLECULAR; ESCAMOSAS DE CABECA E PESCOCO; CELULAS DE CARCINOMA; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR |
| 6/22 | US=50 / Câncer Ferrara N. Vascular endothelial growth factor: basic biology and clinical application. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 11-21. ISBN 978-1-60327-086-1. FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; FACTOR DE CRESCIMENTO; ENDOTELIAL VASCULAR; ENDOTELIO; ANGIOGENESE; TIROSINA-QUINASES; CRESCIMENTO DO TUMOR |
| 7/22 | US=9-A / Ginecologia Dorigo O, Mertínez-Maza O, Berek JS. Biologic, targeted, and immune therapies. In: Berek JS, Hacker NF. Berek and Hacker's gynecologic oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2009. p. 41-56. ISBN 978-0-7817-9512-8. ONCOLOGIA GINECOLOGICA; TERAPIAS BIOLOGICA; IMUNOTERAPIA; ANGIOGENESE; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; INIBIDORES DO RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; HER-2/NEU; COMPONENTES DO SISTEMA IMUNOLOGICO |
| 8/22 | US=103 / Câncer Makwana V, Simmons S, Missailidis S. Aptamers as anticancer agents. In: Missailidis S. Anticancer therapeutics. New Jersey: Wiley Blackwell, 2008. p. 331-45. ISBN 978-0-470-72303-6. AGENTES ANTICANCERIGENOS; APTAMEROS; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; NUCLEOLIN; PROTEINA E2F; FATOR DE CRESCIMENTO DERIVADO DE PLAQUETAS; ANTIGENO PROSTATICO ESPECIFICO DE MEMBRANA |
| 9/22 | US=11-B / Quimioterapia Asatiani E, Cheson BD. Chemotherapy of the myelodysplastic syndromes. In: Perry MC. The chemotherapy source book. 4th ed. Philadelphia: Wolters Kluwer, 2008. p. 552-9. ISBN 978-0-7817-7328-7. QUIMIOTERAPIA; SINDROMES MIELODISPLASICAS; BIOLOGIA MOLECULAR; CITOGENETICA; IMUNOMODULADORES; FATOR DE NECROSE TUMORAL; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; TRIOXIDO DE ARSENICO; TRANSPLANTE DE CELULAS TRONCO |
| 10/22 | US=23-C / Câncer Sun XF, Zhang H. Role of stromal variables in development and progression of colorectal cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 171-82. ISBN 978-1-4020-9544-3. CANCER COLORRETAL; TRATAMENTO; ESTROMA; ANGIOGENESE; LINFANGIOGENESE; MICROVASOS; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; DENSIDADE LINFATICA; INFILTRACAO LINFOCITICA; PINCH; METALOPROTEINASES; ESTROMELISINA-3 |
| 11/22 | US=67 / Biol/Mol Sundermeyer ML, Bellacosa A, Meropol NJ. Molecular targeting of colorectal cancer: an idea whose time has come. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 117-31. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CANCER COLORRETAL; SEGMENTACAO MOLECULAR; RECEPTOR DE FATOR DE CRESCIMENTO EPIDERMICO; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR |
| 12/22 | US=67 / Biol/Mol Atieh DM, Vahdat LT. Targeted therapy for beast cancer. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 309-42. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CANCER DE MAMA; TERAPIA-ALVO; TRASTUZUMABE; HER-2; MICROARRAY; BEVACIZUMABE; VEGF; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; LAPATINIBE; ANTICORPOS MONOCLONAIS; INIBIDOR DA TIROSINA QUINASE |
| 13/22 | US=67 / Biol/Mol Saini S, Hurwitz H. VEGF inhibition for cancer therapy. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 573-84. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. INIBICAO DO VEGF; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; TERAPIA DO CANCER; ANTI-ANGIOGENESE; INIBICAO DA QUINASE DE TIROSINA; BEVACIZUMABE; SORAFENIBE; BAY 43-9006; MALATO DE SUNITINIBE; SU11248; VATALANIBE |
| 14/22 | US=67 / Biol/Mol Kitzen JJEM, de Jonge MJA, Verweij J. How to define treatment sucess or failure if tumors do not shrink: consequences for trial design. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 657-74. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. MARCADOR SUBSTITUTO; TECIDO SUBSTITUTO; RECEPTOR DE FATOR DE CRESCIMENTO EPIDERMICO; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; INIBIDOR DA FARNESIL TRANSFERASE; SELECAO DE PACIENTE; IMAGEM; PROJETO DESCONTINUACAO RANDOMIZADO; INDICE DE MODULACAO DO CRESCIMENTO; TAXA DE PROGRESSAO; TAXA LIVRE DE PROGRESSAO |
| 15/22 | US=23 / Odontologia Kim ES, Rieber AG. Novel therapeutics for head and neck cancer. In: Werning JW. Oral cancer: diagnosis, management, and rehabilitation. New York: Thieme Medical, 2007. p. 325-33. ISBN 978-3-13-135811-0. CANCER DE CABECA E PESCOCO. TERAPIA; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; TERAPIA DE SUBSTITUICAO DE GENES; INIBIDORES DE FARNESIL TRANSFERASE |
| 16/22 | US=2 / Mama Sarmiento R, Franceschini R, Meo S, Gion M, Longo R, Gaspirini G. Predictive biomarkers in body fluids: circulating vascular endothelial growth factor. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 267-92. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; FLUIDOS CORPORAIS; CIRCULACAO; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; CANCER DE MAMA; ANGIOGENESE; TERAPIA; PROGNOSTICO |
| 17/22 | US=3 / Ginecologia Smola-Hess S, Pfister H. Immune evasion in genital papillomavirus infection and cervical cancer: role of cytokines and chemokines. In: Campo MS. Papillomavirus research: from natural history to vaccines and beyong. Wymondham: Caister Academic Press, 2006. p. 321-39. ISBN 1-904455-04-2. PAPILOMAVIRUS HUMANO; HPV; EVASAO IMUNE; PAPILOMAVIRUS GENITAL; CANCER CERVICAL; CITOCINAS; QUIMIOCINAS; MICROAMBIENTE DA MUCOSA; PROTEINA INFLAMATORIA MACROFAGICA-3ALFA; INTERLEUCINA-10; FATOR DE CRESCIMENTO TRANSFORMADOR-BETA; INTERLEUCINA-6; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; NECROSE TUMORAL-ALFA; TNF-ALFA; CD40 |
| 18/22 | US=45 / Urologia Brehmer B, Makris A, Jakse G. New serum markers for prostate cancer. In: Bowsher W, Carter A. Challenges in prostate cancer. 2nd ed. Oxford: Blackwell Science, 2006. p. 26-39. ISBN 978-1-4051-0752-9. CANCER DE PROSTATA; MARCADORES SERICOS; MARCADORES NEUROENDOCRINOS; FATOR DE CRESCIMENTO INSULINICO; CITOCINAS; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; FATOR DE TRANSFORMACAO DO CRESCIMENTO BETA; INTERLEUCINA-6; METALOPROTEINASES DA MATRIZ; PROTEOMICA DE SORO |
| 19/22 | US=123-A / Câncer Chantre M, Ornellas AA, Alves G. Aspectos moleculares dos tumores uroteliais. In: Figueiredo EMA, Correia MM, Oliveira AF. Tratado de oncologia. Rio de Janeiro: Revinter, 2013. p. 1685-90. ISBN 978-85-37205402. TUMORES UROTELIAIS; ANTIGENO TUMORAL DE BEXIGA (BTA); PROTEINA DA MATRIZ NUCLEAR (NMP-22); TELOMERASE; MARCADORES GENETICOS; RECEPTOR DO FATOR DE CRESCIMENTO DE FIBROBLASTOS (FGFR3); RECEPTOR DO FATOR DE CRESCIMENTO EPITELIAL (EGFR); PROTEINA SUPRESSORA TUMORAL (P53); RUNT-RELATED TRANSCRIPTION FATOR 3 (RUNX3); RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1 (RASSF1); FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR (VEGF); METALOPROTEINASES DA MATRIZ (MMP); BLCA-4; E-CADERINA; SURVIVINA |
| 20/22 | US=120 / Câncer Fernandes GS. Terapia antiangiogênica em oncologia. In: Hoff PMG. Tratado de oncologia. São Paulo: Atheneu, 2013. p. 849-855. ISBN 85-388-0312-6. FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR NO CANCER; AGENTES TERAPEUTICOS ANTIANGIOGENICO; ESTRATEGIAS NAO BASEADAS NO VEGF |